Skip to main content
The Canadian Journal of Infectious Diseases logoLink to The Canadian Journal of Infectious Diseases
. 1997 Sep-Oct;8(5):279–285. doi: 10.1155/1997/756754

Does Vibrio vulnificus present a health threat to Canadians?

Stanislava Stavric 1, Barbara Buchanan 1,
PMCID: PMC3250891  PMID: 22346524

Abstract

OBJECTIVE:

To review recent data on Vibrio vulnificus and its properties, characteristics of disease and epidemiology, sources of infection, population at risk, infectious dose, documented cases of infection and health risk from V vulnificus infection in Canada.

DATA SOURCE:

A MEDLINE and CURRENT CONTENTS search (1981 through September 1996) using the main heading ‘Vibrio vulnificus’, ‘Vibrio species’, ‘seafood’, etc. Relevant articles were also selected from the literature collection in the authors’ laboratory.

STUDY SELECTION AND DATA EXTRACTION:

The authors judged articles relevant to the objective of the paper and selected them for a review.

DATA SYNTHESIS:

V vulnificus, an important cause of septicemia, wound infections and gastroenteritis, is considered to be one of the most invasive and rapidly lethal human pathogens. Molluscan shellfish concentrate this organism from warm seawater and present the greatest danger to consumers. Infections with this pathogen have been reported throughout the world. Most deaths have resulted from the consumption of raw or undercooked oysters, fewer from contact with seawater. Individuals with underlying disease, particularly those with liver diseases and iron overload, are the most susceptible.

CONCLUSION:

The two reported cases of V vulnificus wound infection in Canada might not represent the real situation. Infection with this organism may go unrecognized, unreported or simply may not occur. Medical professionals need to become aware of this pathogen and the dire consequences of infection in individuals with underlying disease.

Keywords: Oysters, Septicemia, Vibrio vulnificus, Wound infections


Vibrio vulnificus is considered one of the most invasive and rapidly lethal human pathogens (1). It causes sporadic cases of primary septicemia, gastroenteritis and severe wound infection. Persons who have pre-existing illness, especially those with liver dysfunction, are at the greatest risk of infection. In these individuals, the mortality rate despite treatment exceeds 50%; without treatment, the mortality rate can be 100% (2). Most cases in North America have occurred in the southeastern United States where this organism has emerged as a leading cause of deaths associated with consumption of seafood.

The organism is acquired mainly through the consumption of raw or undercooked molluscan shellfish, but it can also enter through skin lesions following exposure to seawater (eg, handling shellfish, bathing). It occurs naturally in warm waters, and its presence is not associated with fecal contamination. Because known shellfish control measures do not prevent or eliminate V vulnificus from shellfish (3), this organism’s presence is generating much concern in the shellfish and food services industries, in regulatory agencies and among health officials. Currently, education of the public at risk, as well as shellfish providers (industry and restaurants), appears to be the only effective measure for preventing infection with V vulnificus.

This paper reviews recent information about this organism to increase awareness of its dangers to the public.

CHARACTERISTICS OF THE ORGANISM

The genus Vibrio contains several human pathogens of which Vibrio cholerae, Vibrio parahaemolyticus and Vibrio vulnificus are the most common disease-causing organisms. Other pathogenic species include Vibrio fluvialis, Vibrio mimicus, Vibrio alginolyticus and Vibrio metchnikovii (4). In this paper they will be referred to as pathogenic vibrios (PV).

V vulnificus is the most virulent species of noncholera vibrios. It is found in estuarine seawaters of temperate and tropical climates and is associated with various marine life forms (5). Because molluscs are filter-feeders, they strain and concentrate particulate matter including V vulnificus. Therefore, the organism has been found in high concentrations in oysters and other shellfish from different parts of the world. In North America, V vulnificus is prevalent in areas bordering the Gulf of Mexico. Coincidentally, these areas also have the largest number of reported illnesses and deaths attributed to shellfish consumption. However, the organism has also been isolated from cooler waters, and molluscan shellfish sampled from other locations (including Maryland, New England, Maine, Nova Scotia, New Brunswick, Prince Edward Island [PEI], British Columbia and California) where the incidence of disease is very low or not reported.

This Gram-negative curved rod is motile, oxidase positive and ferments glucose and cellobiose. It is an obligate halophile requiring an optimum sodium chloride concentration between 1% and 3% for growth under laboratory conditions (1). In nature, a combination of water temperature and salinity plays an important role in its survival (6). In seawater, it is more prevalent at temperatures above 20°C and at salinities of 0.7% to 1.6%. It is rarely found in water cooler than 17°C (7,8). Recently, however, V vulnificus has been isolated from oysters in water with temperature as low as 7.6°C (9).

CHARACTERISTICS OF DISEASE AND EPIDEMIOLOGY

V vulnificus causes three distinct clinical syndromes: primary septicemia, gastroenteritis and wound infection. This organism is unusual in that it has the ability to cause infection by two different routes of entry, either by mouth or through skin lesions. The most susceptible are individuals with underlying illness. Raw oysters and seawater have consistently been implicated in the epidemiology of this disease. Following ingestion of the bacterium, a primary septicemia with a high case fatality rate occurs. Entry of the bacterium through a skin lesion usually results in a lower overall fatality rate. Each syndrome is described below.

Primary septicemia:

Primary septicemia, the most severe form of disease, occurs when food containing V vulnificus organisms is consumed. The incubation period before onset of symptoms is quite short, ranging from as little as 7 h to several days. Median incubation periods ranging from 16 to 38 h have been reported (1). Symptoms listed in decreasing order of frequency include fever, chills, hypotension, nausea, vomiting, diarrhea, abdominal pain and secondary skin lesions. A sharp drop in blood pressure can lead to intractable shock and death. Seventy-five per cent of patients experience painful skin lesions (7). The skin initially appears red and quickly develops blisters that erode into necrotic ulcers. Severe acute inflammation may force either debridement or amputation.

More than 95% of patients with primary septicemia have pre-existing chronic illness, and over 50% of these patients die. The time between exposure and death is usually only a few days, but patients dying within 2 to 24 h of admission to hospital have frequently been reported (1,10); a median time from admission to death is 48 h or less (11,12). Many deaths occurred despite extensive use of a wide variety of antibiotics. Infections seemed to have been well involved by the time a patient sought medical attention. Experimental studies have revealed tetracycline to be the most effective of the antibiotics evaluated (1,7).

Gastroenteritis:

Consumption of food containing V vulnificus may also cause gastroenteritis. Patients experience relatively milder symptoms than in septicemia. Symptoms of gastroenteritis consist of vomiting, diarrhea and abdominal cramps. Affected patients usually do not have an underlying disease. They may require hospitalization, but rarely die (11).

Wound infections:

Wound infections can occur when the organism enters skin lesions exposed to seawater or when skin is punctured while handling shellfish or from marine animal bites (1). Incubation periods as short as 4 h have been reported, with an average of 12 h. Symptoms typically begin with edema, erythema and intense pain around the infected site. Fluid-filled blisters often develop and progress to tissue necrosis. In its speed and severity, this process resembles gas gangrene. In 50% of cases, surgical debridement or amputation is required to stop the spread of the organism into the bloodstream, which can result in septicemic death (12,13). In general, mortality rates for wound infections are approximately 25%, but for patients with a pre-existing chronic illness, they can be greater than 50% (1).

Summaries of clinical signs, symptoms and risk factors associated with many cases (8,12,14,15) are shown in Tables 1 and 2. Additional information can be obtained from recent reviews and case studies (1,2,10,11,13,1619).

TABLE 1.

Summary of the signs, symptoms and risk factors associated with Vibrio vulnificus primary septicemia

Signs, symptoms and risk factors Primary septicemia
Klontz et al (14) Park et al (15) Chang et al (8) Tacket et al (12)
Number of patients 38 70 14 18
Mean age (years) 62.5 51 53.6 56.4
Age range (years) 23–84 23–69
Sex (male/female) 33/5 67/3 10/4 13/5
Temperature at admission >37.8°C
Leukocyte count (/L) Leukopenia 14/59 8 (44%) >1.0×1010*
Leukocytosis 20/59 6 (33%) <4.0×109*
Platelet count (/L) Thrombocytopenia 26/38 12 (67%)* <1.0×1011
Symptoms N (%) N (%) N (%) N (%)
Systemic
  Fever 35 (92%) 38 (54%) 14 (100%) 17 (94%)
  Chills 20 (53%) 23 (33%) 13 (93%) 16 (91%)
  Mental status change 19 (50%) 5 (36%)
  Hypotension§ 13 (32%) 38 (54%) 11 (79%) 6 (33%)
Gastrointestinal
  Diarrhea 16 (42%) 23 (33%) 4 (29%) 7 (40%)
  Abdominal pain 13 (34%) 26 (37%) 8 (44%)
  Vomiting 16 (42%) 14 (20%) 3 (21%) 8 (46%)
Skin
  Cellulitis 19 (50%)
  Bullae 14 (37%) 29 (42%) 12 (86%)
  Ecchymosis 13 (32%)
  Cutaneous lesions 63 (91%) 12 (86%) 12 (67%)
Risk factors
Comorbid illness – liver disease
  Alcoholism 12 (32%) 30/65 (46%) 5 (36%) 9 (50%)
  Other 13 (34%) 47/65 (72%) 9 (64%) 3 (17%)
Comorbid illness – nonliver related 24 (63%) 5/65 (8%) 3 (17%)
Consumption of raw shellfish 35 (92%) 44 (63%) 9 (64%) 16 (87%)
Wound exposed to seawater or handling shellfish 0 (0%) 1 (7%)
*

Combined results for primary septicemia and wound infection cases (Table 2) reported by Chang et al (8);

Temperature >39.5°C;

Disorientation or lethargy;

§

Systolic blood pressure less than 85 mmHg. N Number

TABLE 2:

Summary of the signs, symptoms and risk factors associated with Vibrio vulnificus wound infections and gastroenteritis

Wound infections Gastroenteritis
Signs, symptoms and risk factors Klontz et al (14) Chang et al (8) Tacket et al (12) Klontz et al (14)
Number of patients 17 4 9 7
Mean age (years) 61 66.5 52.4 66
Age range (years) 56–75
Sex (male/female) 16/1 3/1 7/2 3/4
Temperature at admission >37.8°C >37.8°C
Symptoms N (%) N (%) N (%) N (%)
Systemic
  Fever* 11 (65%) 4 (100%) 8 (88%) 4 (57%)
  Chills 5 (29%) 4 (100%) 9 (100%) 3 (43%)
  Mental status change 3 (18%) 1 (25%) 0 (0%)
  Hypotension 2 (12%) 2 (50%) 2 (22%) 0 (0%)
Gastrointestinal
  Diarrhea 1 (6%) 2 (50%) 1 (12%) 7 (100%)
  Abdominal pain 0 (0%) 0 (0%) 7 (100%)
  Vomiting 1 (6%) 2 (50%) 5 (50%) 2 (29%)
Skin
  Cellulitis 15 (88%) 0 (0%)
  Bullae 7 (41%) 2 (50%) 0 (0%)
  Ecchymosis 3 (18%) 0 (0%)
  Cutaneous lessions 4 (100%) 2 (22%)
Risk factors
Comormid illness – liver disease
  Alcoholism 1 (25%)
  Other 2 (12%) 1 (12%) 2 (29%)
Comormid illness – nonliver related 6 (35%) 2 (50%) 4 (44%)
Consumption of raw shellfish 0 (0%) 5 (71%)
Wound exposed to seawater or handling shellfish 15 (88%) 4 (100%) 8 (88%)
*

Temperature higher than 39.5°C;

Disorientation or lethargy;

Systolic blood pressure less than 85 mmHg. N Number

SOURCES OF INFECTION

The main sources of V vulnificus infection are raw or undercooked molluscan shellfish. Of the primary septicemia cases reported to the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, until 1991, 100% of cases were associated with the consumption of raw or undercooked oysters (20). More recently, raw clams have been also implicated (21). In most of the American cases, Crassostrea virginica, the eastern oyster harvested in the Gulf of Mexico during warm months was involved (22). About 85% of all reported cases were associated with freshly opened oysters consumed raw or undercooked in restaurants. Remaining cases were from shellfish purchased from retail or wholesale markets (11). Retail shucked oysters have not been incriminated in illness. V vulnificus has also been found in oysters harvested during the summer from the northern Atlantic coast, eg, Maryland (9), Maine (23), Nova Scotia (24), PEI (25), and the Pacific coast, eg, British Columbia (26) and California (27). These oysters reportedly have not been implicated in disease. Similarly, several species of bottom feeding fish from the Gulf of Mexico found to contain V vulnificus (28) were never implicated in disease, most probably because the fishes were not eaten raw.

Seawater has been a common source of wound infections. Large numbers of cases resulting from infection via skin have been reported in different parts of the world, eg, United States (18), Canada (29,30), Denmark (31,32) and Taiwan (8).

POPULATION AT RISK

Certain individuals who have a pre-existing chronic illness – such as liver disease including cirrhosis, hemochromatosis and chronic alcohol abuse; diabetes mellitus; immune disorders associated with AIDS, cancer and steroid or immunosuppresant therapy; and stomach and intestinal disorders – are at higher risk of infection than the general public (19). For cases of primary septicemia, between 60% and 75% of patients have pre-existing liver disease or chronic alcoholism, while another 15% to 20% of patients have iron storage diseases such as hemochromatosis or chronic diseases of the immune system (11).

Although most patients with primary septicemia have pre-existing chronic illness, they do not appear to be more sensitive than healthy people to wound infection. Once infected, however, they are at higher risk of developing bacteremia and possibly dying (11).

INFECTIOUS DOSE

The infectious dose for healthy individuals is not known. Reported estimates are as low as 1 colony forming unit (CFU) (33) and less than 100 CFU (34) per predisposed persons with elevated serum iron concentrations, or 100 to 1000 CFU/g of oyster meat (22). The number of raw oysters consumed by patients who died varied from one to about two dozen, but the concentration of V vulnificus in these oysters was not known (11). In one fatal case, analysis of oysters obtained from the implicated lot at the restaurant showed V vulnificus levels to be 900 CFU/g of oyster meat (22). A dose of 1 CFU per person listed above appears too low, and supportive information for this value is lacking. Generally, it has been very hard to locate implicated oysters several days after the reported infection, making assessment of bacteria levels in implicated oysters difficult (22).

DOCUMENTED CASES OF V VULNIFICUS INFECTION

United States:

Most V vulnificus infections are reported in the southeastern United States, and no outbreaks involving two or more individuals have been recorded by the CDC (11,20). So far, cases of infection have been reported in at least 14 states (19). In Florida between 1981 and 1993, 114 persons were hospitalized, with 50 deaths reported (35,36). Reports included 71 cases of primary septicemia, 34 of wound infections and nine of gastroenteritis. In California, during approximately the same time period (1981 to 1992), 24 cases resulted in 18 deaths (37). Infections showed a seasonal pattern, with most occurring from March through December and the highest frequency of cases occurring between May and October. Oysters, harvested from the Gulf of Mexico and consumed raw or undercooked, were implicated as the main source of illness. Of patients who died, about 70% had pre-existing liver disease. In 1995, 23 cases resulted in 10 deaths; clams were implicated in four cases (21). There are limited data available before 1988 because V vulnificus infection was not a reportable disease, except in Florida. Since 1987, other Gulf states (Alabama, Louisiana, Texas and Mississippi) have formed a surveillance system.

Canada:

V vulnificus infection is not a reportable disease in Canada; therefore, information about infection with this organism is lacking. Out of several illnesses caused by pathogenic Vibrio species (PV) only infection by V cholerae must be reported. The limited information available on infections caused by V vulnificus and other PV is outlined below.

There are no published reports of any foodborne infections caused by V vulnificus, although this organism is present in Canadian waters and shellfish during warm summer months on the east and west coasts (2426). One V vulnificus wound infection was reported 10 years ago; it involved an alcoholic male who punctured his skin during the summer on the shore of New Brunswick (29). Recently, reference was made to another person who contracted an infection while swimming in the ocean in the Vancouver area (30).

Infection from other pathogenic Vibrio species have been reported. From 1985 to 1994, there were 22 reported cases of cholera (38). Information about infections with other Vibrio species is lacking. To the authors’ knowledge, only one paper, a note and a reference on marine vibrio infections acquired in Canada have been published (29,39,40). All reported were wound infections, two cases of V alginolyticus infection and two cases of V vulnificus infection.

The evidence, obtained from the Laboratory Centre for Disease Control (LCDC), indicated that the number of cases of vibrio infections occurring in Canada is very small (personal communication). All cases of V cholerae 01 and 0139 were acquired by persons travelling abroad, while infections with V cholerae non-01 and V parahaemolyticus were mostly acquired domestically. Even more rare are infections with V alginolyticus, V mimicus and V fluvialis. The epidemiological background for most of the infections except for V cholerae 01 and 0139 is incomplete or lacking.

Other countries:

Reported cases of infection with V vulnificus for the period from 1981 to 1992 from several countries reveals over 300 cases of primary septicemia and over 100 wound infections, resulting in over 200 deaths (40). Cases and deaths have been reported throughout the world: India (41), Korea (15), Taiwan (8,42), Hong Kong (43), Australia (10), Denmark (31,32), Belgium (44), Sweden (45), The Netherlands (46,47) and other countries. It is unclear whether the recent increase in reported cases of infection represents a true increase in incidence or improved diagnosis and reporting. In the majority of primary septicemic cases, deaths were related to the consumption of raw oysters by persons with underlying illness. Wound infections, contracted after exposure to seawater during activities, such as fishing, bathing, handling oyster shells or eels, etc, resulted in some deaths.

HEALTH RISK FROM V VULNIFICUS INFECTION IN CANADA

Infections from V vulnificus in Canada can occur from shellfish that is either harvested domestically or imported, and from contact of ruptured skin with seawater in summer months.

Domestically harvested shellfish:

V vulnificus has been found in both Canadian coastal waters and in shellfish during the summer months (water temperature greater than 19°C). On the east coast, V vulnificus has been isolated from mussels and seawater in seven recreational areas around Halifax in 1988 (24); clams and mussels in New Brunswick in 1991 and 1992 (personal communication); and oysters and mussels from six river systems in PEI in 1991 and 1992 (25).

The Halifax study (24) demonstrated that the majority (72%) of water samples contained up to 11 different PV species. V alginolyticus was predominant, while V vulnificus and V cholerae were more prevalent in the mussels than in the waters from which the mussels were harvested. There were no PV-associated infections documented among patients presenting to emergency rooms over the study period. In PEI, the most prevalent PV were V alginolyticus (7.1%) and V parahaemolyticus (4.7%). V vulnificus of biotype 2 was present in 6.7% of the oysters and 2.4% of the mussels analyzed.

The presence of biotype 2, which is pathogenic for eels and is differentiated from biotype 1 on the basis of the indole reaction, had not been previously reported in Canada. Biotype 2 has generally not been associated with human illness, and it was accepted that only biotype 1 is pathogenic for humans (48). However, recent reports may indicate otherwise: biotype 2 was isolated from a patient with septicemia and skin lesions in The Netherlands (46); and clinical strain ATCC 33817, originally isolated from a human leg wound and classified only as V vulnificus, was found to belong to biotype 2 (49).

Oysters collected from natural and cultivated populations in British Columbia during the summers of 1984 and 1985 also revealed the presence of PV (26,30). The most commonly isolated organisms were V parahaemolyticus, V fluvialis and V vulnificus. These were more prevalent in oysters from natural sources than from cultivated commercial stocks. Although 50% of the oysters analyzed contained PV, V vulnificus was recovered in only 21% of them. This organism was also isolated from protected estuarine environments, but only when water temperatures exceeded 20°C (30).

These results indicate that oysters harvested from the warm domestic waters contained PV including V vulnificus. The highest quantity of oysters consumed in eastern and central Canada comes from PEI, where the main harvesting season is between May and December. Because a considerable number of these oysters are marketed and reportedly consumed raw (personal communication), consumers with underlying disease could be at risk. Oysters from British Columbia do not represent such a risk because they are reportedly sold as shucked and not consumed raw (personal communication).

Imported shellfish:

Of greater risk to Canadians are imports from the Gulf of Mexico because oysters harvested there have been consistently associated with infections and fatalities in the United States. Gulf oysters comprise about 3% of the total oyster consumption in Canada. They are imported throughout the year to Quebec (85%) and Ontario (15%), with the majority arriving between October and May. Import data for 1993 and 1994 showed that about 40% of the yearly quantity arrived in November (50).

In 1995, a collaborative survey conducted by Health Canada and the Department of Fisheries and Oceans showed that oyster shipments received between January and April did not contain V vulnificus. However, substantial levels of the organism were detected in shipments received between May and November, with the highest concentrations in July and August (unpublished data). These findings parallel results of Gulf oyster analyses conducted in the United States, where the highest concentrations of V vulnificus were detected in the summer (51). They are also in agreement with a study showing that V vulnificus survived in shellstock for at least 14 days at 2 to 3°C (52). Therefore, when high levels of this organism are present at harvest the levels are not likely to be significantly reduced during transport and storage of oysters at low temperature.

Although the majority of Gulf oysters are imported during the cold months, when V vulnificus levels are low or not detectable at the point of harvest, generally there has been a small, but steady supply of contaminated oysters entering the Canadian market from April through October when concentrations of the organism can be high. If such oysters are consumed raw or undercooked, they represent a great health risk to consumers, especially to persons with underlying diseases.

Seawater:

Because V vulnificus has been found off both Canadian coasts during the warm summer months (2426), people with skin lacerations exposed to seawater are at risk of contracting infection. The outcome of infection is more serious for individuals with underlying disease, but persons in apparently good health have also been affected (1,53).

It should be noted that the mere presence of V vulnificus in oysters or seawater is not an indication that this organism will cause disease in humans. Because the factor(s) responsible for the pathogenicity of V vulnificus have not been elucidated, means are not available to predict whether strains present in shellfish are virulent for humans. Also, oysters harvested from the same location can harbour a wide variety of strains; for instance, analysis of three oysters in Florida showed that they contained 60 different V vulnificus genotypes (54). It is possible that strains of V vulnificus present in Canadian shellfish might not be pathogenic. This notion derives from the observation that oysters harvested from the northern coasts of the United States and Canada contained the organism, but these oysters have never been implicated in foodborne infections.

CONCLUSIONS

V vulnificus represents a potential health risk to Canadians. Physicians should warn patients with underlying illness, particularly those with liver diseases and iron overload, about the risk of consuming raw molluscan shellfish because the shellfish may contain V vulnificus. Especially dangerous are imported oysters harvested in the Gulf of Mexico between April and October. Another source of infection to people in high risk categories as well as the general population is exposure of skin lesions to warm seawater during summer months. In addition, susceptible individuals travelling during the summer on the Gulf coast in the southern United States should be warned of the dangers presented by this organism.

Because of the speed at which this disease advances, the timing of medical intervention is critical. Persons developing disease symptoms within a day or two after consumption of raw or undercooked molluscan shellfish or after exposure of open skin to seawater should seek immediate medical attention. Physicians have to become more familiar with the diagnosis and treatment of this disease. Appropriate antibiotic treatment should be administered immediately, and in parallel, laboratories should culture specimens from suspected cases on media appropriate for the isolation of V vulnificus and refer isolates to LCDC for confirmation. Suspected cases of V vulnificus infection should also be reported to the local and provincial health departments so that appropriate investigation and prevention measures can be undertaken.

REFERENCES

  • 1.Oliver JD. Vibrio vulnificus. In: Doyle MP, editor. Foodborne Bacterial Pathogens. 1st edn. New York: Marcel Dekker; 1989. pp. 569–600. [Google Scholar]
  • 2.Dayal HH, Trieff NM, Dayal V. Preventing Vibrio vulnificus infections: Who should bear responsibility? Am J Prev Med. 1993;9:191–3. [PubMed] [Google Scholar]
  • 3.Groubert TN, Oliver JD. Interaction of Vibrio vulnificus and the eastern oyster Crassostrea virginica. J Food Prot. 1994;57:224–8. doi: 10.4315/0362-028X-57.3.224. [DOI] [PubMed] [Google Scholar]
  • 4.Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST, editors. Bergey’s Manual of Determinative Bacteriology. 9th edn. Baltimore: Williams & Wilkins; 1994. Genus vibrio; pp. 192–4. [Google Scholar]
  • 5.Tamplin ML, Capers GM. Persistence of Vibrio vulnificus in tissues of Gulf Coast oysters, Crassostrea virginica, exposed to seawater disinfected with UV light. Appl Environ Microbiol. 1992;58:1506–10. doi: 10.1128/aem.58.5.1506-1510.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kaspar CW, Tamplin ML. Effects of temperature and salinity on the survival of Vibrio vulnificus in seawater and shellfish. Appl Environ Microbiol. 1993;59:2425–9. doi: 10.1128/aem.59.8.2425-2429.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Koenig KL, Mueller J, Rose T. Vibrio vulnificus hazard on the half shell. West J Med. 1991;155:400–3. [PMC free article] [PubMed] [Google Scholar]
  • 8.Chang JJ, Sheen IS, Peng SM, Chen PC, Wu CS, Leu HS. Vibrio vulnificus infection – Report of 8 cases and review of cases in Taiwan. Chang Gung Med J. 1994;17:339–46. [PubMed] [Google Scholar]
  • 9.Wright AC, Hill RT, Johnson JA, Roghman MC, Colwell RR, Morris JG., Jr Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol. 1996;62:717–24. doi: 10.1128/aem.62.2.717-724.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wise KA, Newton PJ. A fatal case of Vibrio vulnificus septicemia. Pathology. 1992;24:121–2. doi: 10.3109/00313029209063637. [DOI] [PubMed] [Google Scholar]
  • 11.Whitman C. Overview of the important clinical and epidemiologic aspects of Vibrio vulnificus infections. In: Watkins W, McCarthy S, editors. Proceedings of the 1994 Vibrio vulnificus Workshop. 1st edn. Washington: Food and Drug Administration; 1994. pp. 13–23. [Google Scholar]
  • 12.Tacket CO, Brenner F, Blake PA. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis. 1984;149:558–61. doi: 10.1093/infdis/149.4.558. [DOI] [PubMed] [Google Scholar]
  • 13.Whitman CM, Griffin PM. Preventing Vibrio vulnificus infection in the high risk patient. Infect Dis Clin Pract. 1993;2:275–6. [Google Scholar]
  • 14.Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections. Ann Intern Med. 1988;109:318–23. doi: 10.7326/0003-4819-109-4-318. [DOI] [PubMed] [Google Scholar]
  • 15.Park SD, Shon HS, Joh NJ. Vibrio vulnificus septicemia in Korea: Clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol. 1991;24:397–403. doi: 10.1016/0190-9622(91)70059-b. [DOI] [PubMed] [Google Scholar]
  • 16.Bullen JJ, Spalding PB, Ward CG, Gutteridge JMC. Hemochromatosis, iron, and septicemia caused by Vibrio vulnificus. Arch Intern Med. 1991;151:1606–9. [PubMed] [Google Scholar]
  • 17.Chuang YC, Young C, Chen CW. Vibrio vulnificus infection. Scand J Infect Dis. 1989;12:721–6. doi: 10.3109/00365548909021703. [DOI] [PubMed] [Google Scholar]
  • 18.Penman AD, Lanier DC, Avara WT, III, et al. Vibrio vulnificus wound infections from the Misssissippi Gulf coastal waters: June to August 1993. South Med J. 1995;88:531–3. doi: 10.1097/00007611-199505000-00004. [DOI] [PubMed] [Google Scholar]
  • 19.Hlady G. Florida risk assessment and factors associated with risk. In: Watkins W, McCarthy S, editors. Proceedings of the 1994 Vibrio vulnificus Workshop. 1st edn. Washington: Food and Drug Administration; 1994. pp. 27–37. [Google Scholar]
  • 20.Ahmed FE, editor. Seafood Safety. Washington: National Academy Press; 1991. Microbiological and parasitic exposure and health effects; pp. 30–86. [Google Scholar]
  • 21.Food and Drug Administration, Center for Disease Control and Prevention V vulnificus responsible for 23 cases, 10 deaths so far in 1995. Food Chem News. 1995 Oct 23;37:20. [Google Scholar]
  • 22.Tamplin M. The ecology of Vibrio vulnificus. In: Watkins W, McCarthy S, editors. Proceedings of the 1994 Vibrio vulnificus Workshop. 1st edn. Washington: Food and Drug Administration; 1994. pp. 75–85. [Google Scholar]
  • 23.O’Neill KR, Jones SH, Grimes DJ. Seasonal incidence of Vibrio vulnificus in the Great Bay estuary of New Hampshire and Maine. Appl Environ Microbiol. 1992;58:3257–62. doi: 10.1128/aem.58.10.3257-3262.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Badley A, Phillips B, Haldane DJM, Dalton MT. Pathogenic marine Vibrio species in selected Nova Scotian recreational coastal waters. Can J Public Health. 1990;81:263–7. [PubMed] [Google Scholar]
  • 25.Hariharan H, Giles JS, Heaney SB, Arsenault G, McNair N, Rainnie DJ. Bacteriological studies on mussels and oysters from six river systems in Prince Edward Island, Canada. J Shellfish Res. 1995;14:527–32. [Google Scholar]
  • 26.Kelly MT, Stroh EMD. Occurrence of Vibrionaceae in natural and cultivated oyster populations in the Pacific Northwest. Diagn Microbiol Infect Dis. 1988;9:1–5. doi: 10.1016/0732-8893(88)90054-5. [DOI] [PubMed] [Google Scholar]
  • 27.Kaysner CA, Abeyta C, Jr, Wekell MM, DePaola A, Stott RF, Leitch JM. Virulent strains of Vibrio vulnificus isolated from estuaries of the United States West Coast. Appl Environ Microbiol. 1987;53:1349–51. doi: 10.1128/aem.53.6.1349-1351.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.DePaola A, Capers GM, Alexander D. Densities of Vibrio vulnificus in the intestines of fish from the US Gulf Coast. Appl Environ Microbiol. 1994;60:984–8. doi: 10.1128/aem.60.3.984-988.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abbott LP. Vibrio vulnificus in New Brunswick. Can Dis Wkly Rep. 1986;12–14:57–8. [Google Scholar]
  • 30.Kelly MT. Pathogenic Vibrionaceae in patients and environments. Underseas Biomed Res. 1991;18:193–6. [PubMed] [Google Scholar]
  • 31.Bock T, Christensen N, Eriksen NHR, Winter S, Rygaard H, Jorgensen F. The first fatal case of Vibrio vulnificus infection in Denmark. APMIS. 1994;102:874–6. [PubMed] [Google Scholar]
  • 32.Dalsgaard A, Frimodt-Moller N, Bruun B, Hoi L, Larsen JL. Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis. 1996;15:227–32. doi: 10.1007/BF01591359. [DOI] [PubMed] [Google Scholar]
  • 33.Council for Agricultural Science and Technology . Foodborne Pathogens: Risk and Consequences, Task Force Report No 122. Ames: Council for Agricultural Science and Technology; 1994. p. 14. [Google Scholar]
  • 34.Center for Food Safety and Applied Nutrition . Foodborne Pathogenic Microorganisms and Natural Toxins. Washington: Food and Drug Administration; 1992. Vibrio vulnificus; pp. 1–3. [Google Scholar]
  • 35.Hlady WG, Klontz KC. The epidemiology of vibrio infections in Florida, 1981–1993. J Infect Dis. 1996;173:1176–83. doi: 10.1093/infdis/173.5.1176. [DOI] [PubMed] [Google Scholar]
  • 36.Hlady WG, Mullen RC, Hopkins RS. Vibrio vulnificus infections associated with raw oyster comsumption – Florida, 1981–1992. Arch Dermatol. 1993;129:957–8. [Google Scholar]
  • 37.Kizer KW. Vibrio vulnificus infections and raw oysters. Am J Prev Med. 1994;10:123–4. [PubMed] [Google Scholar]
  • 38.Division of Disease Surveillance, Bureau of Infectious Diseases, Laboratory Centre for Disease Control . Notifiable Diseases Annual Summary 1994. Vol. 42. Ottawa: Health and Welfare Canada; 1996. pp. 108–12. [Google Scholar]
  • 39.Wagner KR, Crichton EP. Marine vibrio infections acquired in Canada. Can Med Assoc J. 1981;124:435–6. [PMC free article] [PubMed] [Google Scholar]
  • 40.Peterkin PI. New pathogens of interest in food – Vibrio vulnificus. Rev Microbiol Sao Paulo. 1994;25:137–43. [Google Scholar]
  • 41.Saraswathi K, Barve SM, Deodhar LP. Septicaemia due to Vibrio vulnificus. Trans R Soc Trop Med Hyg. 1989;83:714. doi: 10.1016/0035-9203(89)90406-9. [DOI] [PubMed] [Google Scholar]
  • 42.Chuang YC, Yuan CY, Liu CY, Lan CK, Huang AHM. Vibrio vulnificus infection in Taiwan: Report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis. 1992;15:271–6. doi: 10.1093/clinids/15.2.271. [DOI] [PubMed] [Google Scholar]
  • 43.Chan TYK, Chow DPM, Ng KC, Pang KW, McBride GA. Vibrio vulnificus septicemia in a patient with liver cirrhosis. Southeast Asian J Trop Med Public Health. 1994;25:215–6. [PubMed] [Google Scholar]
  • 44.Mertens A, Nagler J, Hansen W, Gepts-Friedenreich E. Halophilic, lactose-positive vibrio in a case of fatal septicemia. J Clin Microbiol. 1979;9:233–5. doi: 10.1128/jcm.9.2.233-235.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Melhus A, Holmdahl T, Tjernberg I. First documented case of bacteremia with Vibrio vulnificus in Sweden. Scand J Infect Dis. 1995;27:81–2. doi: 10.3109/00365549509018980. [DOI] [PubMed] [Google Scholar]
  • 46.Veenstra J, Rietra PJGM, Stoutenbeek CHP, Coster JM, DeGier HHW, Dirks-Go S. Infection by indole-negative variant of Vibrio vulnificus transmitted by eels. J Infect Dis. 1992;166:209–10. doi: 10.1093/infdis/166.1.209. [DOI] [PubMed] [Google Scholar]
  • 47.Veenstra J, Rietra PJGM, Coster JM, Slaats E, Dirks-Go S. Seasonal variations in the occurrence of Vibrio vulnificus along the Dutch coast. Epidemiol Infect. 1994;112:285–90. doi: 10.1017/s0950268800057691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Biosca EG, Amaro C, Esteve C, Garay E. First record of Vibrio vulnificus biotype 2 from diseased European eel, Anguilla anguilla. J Fish Dis. 1991;14:103–9. [Google Scholar]
  • 49.Amaro C, Biosca EG. Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans. Appl Environ Microbiol. 1996;62:1454–7. doi: 10.1128/aem.62.4.1454-1457.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Department of Fisheries and Oceans Inspection . Import Management Information System. 1995:1–21. Internal Document. Ottawa: Department of Fisheries and Oceans; 1995. Fresh Oyster Imports – United States April 1, 1993 to March 31, 1994. [Google Scholar]
  • 51.Cook DW. Effect of time and temperature on multiplication of Vibrio vulnificus in postharvest Gulf Coast shellstock oysters. Appl Environ Microbiol. 1994;60:3483–4. doi: 10.1128/aem.60.9.3483-3484.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kaysner CA, Tamplin ML, Wekell MM, Stott RF, Colburn KG. Survival of Vibrio vulnificus in shellstock and shucked oysters (Crassostrea gigas and C virginica) and the effects of isolation medium on recovery. Appl Environ Microbiol. 1989;55:3072–9. doi: 10.1128/aem.55.12.3072-3079.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hoge CW, Watsky D, Peeler RN, Libonati JP, Israel E, Morris JG., Jr Epidemiology and spectrum of vibrio infections in a Chesapeake Bay community. J Infect Dis. 1989;160:985–93. doi: 10.1093/infdis/160.6.985. [DOI] [PubMed] [Google Scholar]
  • 54.Buchrieser C, Gangar VV, Murphree RL, Tamplin ML, Kaspar CW. Multiple Vibrio vulnificus strains in oysters as demonstrated by clamped homogeneous electric field gel electrophoresis. Appl Environ Microbiol. 1995;61:1163–8. doi: 10.1128/aem.61.3.1163-1168.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Canadian Journal of Infectious Diseases are provided here courtesy of Wiley

RESOURCES